Patent Yard Sign in
Canadian application, no grantCanada

1,4-diazacycloheptane derivatives

CA 2312070 A1 · Owner: Keith, Richard Alan · Inventors: Keith, Richard Alan; Simpson, Thomas Richard; Warawa, Edward John

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula (I): wherein R is hydrogen C1-10alkyl, C3-8cycloalkyl, C3-8cycloalkylC1-6alkyl phenylC1-6alkyl or phenyl; R1 is C1-6alkyl C2-, 6alkenyl, C1-6alkoxy, halo, hydroxy C1-6alkanoyl, haloC1-6alkyl, cyano or nitro; m is 0, 1 or 2; R2 is C1-6alkyl; n is 0 1 or 2; are empomil inhibitors , and are useful in the treatment of neurological disorders such as stroke head , trauma, transient cerebral ischemic attack and chronic neurodegenerative , disorders such as Alzheimer's disease Parkinson's disease, diabetic , neuropathy amyotrophic lateral sclerosis, multiple sclerosis vascular , dementia and AIDS-related dementia.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 15, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 15, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 15, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 15, 1998
GrantedNo grant recorded
Term endedDecember 15, 2018
Patent numberCA 2312070 A1
Classification (IPC)C07D243/08 +1 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedDec 15, 1998Term endedDec 15, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.